Who
John J. Alam
CEO & President
Company insider
Files Form 4 as: CEO & President, CervoMed; EVP, Med. Dev. Group & CMO, Vertex Pharmaceuticals.
In numbers
- Trades disclosed
- 166
- Buys
- 4
- Sells
- 31
- Bought
- $283K
- Sold
- $4.6M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 Feb 2006
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,150 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,150 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 17 Nov 2025filed 19 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $91K10,807 at $8.46 | filing |
| 17 Nov 2025filed 19 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $91K10,793 at $8.46 | filing |
| 14 Nov 2025filed 17 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $13K1,693 at $7.55 | filing |
| 14 Nov 2025filed 17 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $13K1,707 at $7.57 | filing |
| 13 Nov 2025filed 17 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $33K4,447 at $7.51 | filing |
| 12 Nov 2025filed 13 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $41K5,553 at $7.35 | filing |
| 23 Jun 2025filed 25 Jun 2025 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,100 at $0.00 | filing |
| 4 Feb 2025filed 14 Feb 2025 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 14 Jun 2024filed 14 Jun 2024 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 26 Jan 2024filed 26 Jan 2024 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,500 at $0.00 | filing |
| 9 Nov 2023filed 9 Nov 2023 | CRVO CervoMedBiotechnology | SEC FORM 4 Code G | —12,500 at $0.00 | filing |
| 15 Sep 2023filed 15 Sep 2023 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,500 at $0.00 | filing |
| 15 Sep 2023filed 15 Sep 2023 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,450 at $0.00 | filing |
| 1 Oct 2008filed 2 Oct 2008 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,253 at $0.00 | filing |
| 1 Oct 2008filed 2 Oct 2008 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $58K4,253 at $13.63 | filing |
| 1 Oct 2008filed 2 Oct 2008 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $139K4,253 at $32.65 | filing |
News
No headline names them, or the companies they trade most, lately.